The hypothesis that loss of EpCAM expression may be involved in cancer metastasis is further supported by the finding that EpCAM protein expression on circulating tumour cells (CTC) is reduced compared with primary and metastatic tumours [128]. The gene discussed is EPCAM; the disease is neoplasm.